Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Accelevir Diagnostics
company
About
Accelevir Diagnostics is a biotechnology company developing innovative assays for ultra-rare analytes in infectious diseases and beyond.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $224.55K
- Industries
- Biotechnology
- Founded date
- Jan 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$1.42M
Accelevir Diagnostics has raised a total of
$1.42M
in funding over 2 rounds. Their latest funding was raised on
Sep 18, 2017 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 18, 2017 | Grant | $1.19M | 1 |
National Science Foundation
|
— | Detail |
| Jun 24, 2016 | Grant | $224.55K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
Accelevir Diagnostics is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
